Table 1 Baseline characteristics of groups
Characteristic |
Overall, N = 837 |
Cardiac surgery, N = 606 |
NOT Cardiac surgery, N = 231 |
p-value |
surgery_date |
2018-01-29 to 2023-01-14 |
2018-01-29 to 2023-01-14 |
2019-03-19 to 2023-01-03 |
0.3 |
afib_type |
|
|
|
0.044 |
Paroxysmal atrial fibrillation |
439 (52%) |
328 (54%) |
111 (48%) |
|
Unspecified atrial fibrillation |
376 (45%) |
267 (44%) |
109 (47%) |
|
Other specified cardiac arrhythmias |
15 (1.8%) |
7 (1.2%) |
8 (3.5%) |
|
Other persistent atrial fibrillation |
6 (0.7%) |
4 (0.7%) |
2 (0.9%) |
|
Chronic atrial fibrillation, unspecified |
1 (0.1%) |
0 (0%) |
1 (0.4%) |
|
dm |
112 (13%) |
81 (13%) |
31 (13%) |
>0.9 |
mi |
62 (7.4%) |
45 (7.4%) |
17 (7.4%) |
>0.9 |
cva |
45 (5.4%) |
30 (5.0%) |
15 (6.5%) |
0.4 |
copd |
67 (8.0%) |
40 (6.6%) |
27 (12%) |
0.015 |
pad |
229 (27%) |
186 (31%) |
43 (19%) |
<0.001 |
chf |
75 (9.0%) |
56 (9.2%) |
19 (8.2%) |
0.6 |
osa |
75 (9.0%) |
57 (9.4%) |
18 (7.8%) |
0.5 |
hld |
345 (41%) |
267 (44%) |
78 (34%) |
0.007 |
htn |
490 (59%) |
369 (61%) |
121 (52%) |
0.025 |
fup_afib_90days |
168 (20%) |
105 (17%) |
63 (27%) |
0.001 |
ckd |
21 (2.5%) |
14 (2.3%) |
7 (3.0%) |
0.6 |
fup_cva_90days |
15 (1.8%) |
12 (2.0%) |
3 (1.3%) |
0.8 |
sex |
|
|
|
<0.001 |
Male |
524 (63%) |
401 (66%) |
123 (53%) |
|
Female |
313 (37%) |
205 (34%) |
108 (47%) |
|
age |
71 (65, 78) |
71 (65, 77) |
73 (66, 80) |
0.024 |
race |
|
|
|
<0.001 |
White or Caucasian |
761 (91%) |
559 (92%) |
202 (87%) |
|
Other |
50 (6.0%) |
34 (5.6%) |
16 (6.9%) |
|
Black or African American |
16 (1.9%) |
4 (0.7%) |
12 (5.2%) |
|
Asian |
10 (1.2%) |
9 (1.5%) |
1 (0.4%) |
|
anti_coag_at_disch |
518 (62%) |
388 (64%) |
130 (56%) |
0.039 |
anti_coags_at_re_admit_afib |
109 (65%) |
69 (66%) |
40 (63%) |
0.8 |
readmit_afib_date |
2017-08-27 to 2022-10-18 |
2017-11-25 to 2022-10-18 |
2017-08-27 to 2022-09-04 |
0.028 |
days_between_surg_and_af_readmission |
-221 (-681, 154) |
-145 (-619, 179) |
-306 (-900, 4) |
0.028 |
CHADS_TOTAL |
|
|
|
|
4 |
263 (31%) |
200 (33%) |
63 (27%) |
|
5 |
231 (28%) |
167 (28%) |
64 (28%) |
|
3 |
179 (21%) |
125 (21%) |
54 (23%) |
|
6 |
76 (9.1%) |
54 (8.9%) |
22 (9.5%) |
|
2 |
64 (7.6%) |
41 (6.8%) |
23 (10.0%) |
|
7 |
17 (2.0%) |
14 (2.3%) |
3 (1.3%) |
|
1 |
5 (0.6%) |
4 (0.7%) |
1 (0.4%) |
|
8 |
2 (0.2%) |
1 (0.2%) |
1 (0.4%) |
|
Table 2 ONLY CARDIAC SURGERY patients: recurrance VS no recurrance
Characteristic |
Overall, N = 606 |
Afib on 90 day follow up, N = 105 |
NO Afib on 90 day follow up, N = 501 |
p-value |
classification |
|
|
|
|
CS |
606 (100%) |
105 (100%) |
501 (100%) |
|
surgery_date |
2018-01-29 to 2023-01-14 |
2018-01-29 to 2021-09-08 |
2019-03-13 to 2023-01-14 |
<0.001 |
afib_type |
|
|
|
>0.9 |
Paroxysmal atrial fibrillation |
328 (54%) |
57 (54%) |
271 (54%) |
|
Unspecified atrial fibrillation |
267 (44%) |
46 (44%) |
221 (44%) |
|
Other specified cardiac arrhythmias |
7 (1.2%) |
1 (1.0%) |
6 (1.2%) |
|
Other persistent atrial fibrillation |
4 (0.7%) |
1 (1.0%) |
3 (0.6%) |
|
dm |
81 (13%) |
22 (21%) |
59 (12%) |
0.012 |
mi |
45 (7.4%) |
12 (11%) |
33 (6.6%) |
0.085 |
cva |
30 (5.0%) |
7 (6.7%) |
23 (4.6%) |
0.4 |
copd |
40 (6.6%) |
21 (20%) |
19 (3.8%) |
<0.001 |
pad |
186 (31%) |
37 (35%) |
149 (30%) |
0.3 |
chf |
56 (9.2%) |
22 (21%) |
34 (6.8%) |
<0.001 |
osa |
57 (9.4%) |
12 (11%) |
45 (9.0%) |
0.4 |
hld |
267 (44%) |
54 (51%) |
213 (43%) |
0.094 |
htn |
369 (61%) |
75 (71%) |
294 (59%) |
0.015 |
ckd |
14 (2.3%) |
5 (4.8%) |
9 (1.8%) |
0.077 |
fup_cva_90days |
12 (2.0%) |
4 (3.8%) |
8 (1.6%) |
0.14 |
sex |
|
|
|
0.3 |
Male |
401 (66%) |
74 (70%) |
327 (65%) |
|
Female |
205 (34%) |
31 (30%) |
174 (35%) |
|
age |
71 (65, 77) |
71 (64, 78) |
71 (65, 77) |
0.6 |
race |
|
|
|
0.9 |
White or Caucasian |
559 (92%) |
98 (93%) |
461 (92%) |
|
Other |
34 (5.6%) |
5 (4.8%) |
29 (5.8%) |
|
Asian |
9 (1.5%) |
2 (1.9%) |
7 (1.4%) |
|
Black or African American |
4 (0.7%) |
0 (0%) |
4 (0.8%) |
|
anti_coag_at_disch |
388 (64%) |
85 (81%) |
303 (60%) |
<0.001 |
anti_coags_at_re_admit_afib |
69 (66%) |
69 (66%) |
0 (NA%) |
|
readmit_afib_date |
2017-11-25 to 2022-10-18 |
2017-11-25 to 2022-10-18 |
NA to NA |
|
days_between_surg_and_af_readmission |
-145 (-619, 179) |
-145 (-619, 179) |
NA (NA, NA) |
|
CHADS_TOTAL |
|
|
|
0.3 |
4 |
200 (33%) |
33 (31%) |
167 (33%) |
|
5 |
167 (28%) |
33 (31%) |
134 (27%) |
|
3 |
125 (21%) |
15 (14%) |
110 (22%) |
|
6 |
54 (8.9%) |
10 (9.5%) |
44 (8.8%) |
|
2 |
41 (6.8%) |
8 (7.6%) |
33 (6.6%) |
|
7 |
14 (2.3%) |
5 (4.8%) |
9 (1.8%) |
|
1 |
4 (0.7%) |
1 (1.0%) |
3 (0.6%) |
|
8 |
1 (0.2%) |
0 (0%) |
1 (0.2%) |
|
Table 3 ONLY NON-CS patients: recurrance VS no recurrance
Characteristic |
Overall, N = 231 |
Afib on 90 day follow up, N = 63 |
NO Afib on 90 day follow up, N = 168 |
p-value |
classification |
|
|
|
|
NCS |
231 (100%) |
63 (100%) |
168 (100%) |
|
surgery_date |
2019-03-19 to 2023-01-03 |
2019-08-14 to 2021-09-07 |
2019-03-19 to 2023-01-03 |
<0.001 |
afib_type |
|
|
|
0.020 |
Paroxysmal atrial fibrillation |
111 (48%) |
40 (63%) |
71 (42%) |
|
Unspecified atrial fibrillation |
109 (47%) |
23 (37%) |
86 (51%) |
|
Other specified cardiac arrhythmias |
8 (3.5%) |
0 (0%) |
8 (4.8%) |
|
Other persistent atrial fibrillation |
2 (0.9%) |
0 (0%) |
2 (1.2%) |
|
Chronic atrial fibrillation, unspecified |
1 (0.4%) |
0 (0%) |
1 (0.6%) |
|
dm |
31 (13%) |
14 (22%) |
17 (10%) |
0.016 |
mi |
17 (7.4%) |
8 (13%) |
9 (5.4%) |
0.086 |
cva |
15 (6.5%) |
3 (4.8%) |
12 (7.1%) |
0.8 |
copd |
27 (12%) |
11 (17%) |
16 (9.5%) |
0.095 |
pad |
43 (19%) |
12 (19%) |
31 (18%) |
>0.9 |
chf |
19 (8.2%) |
9 (14%) |
10 (6.0%) |
0.040 |
osa |
18 (7.8%) |
9 (14%) |
9 (5.4%) |
0.049 |
hld |
78 (34%) |
24 (38%) |
54 (32%) |
0.4 |
htn |
121 (52%) |
42 (67%) |
79 (47%) |
0.008 |
ckd |
7 (3.0%) |
3 (4.8%) |
4 (2.4%) |
0.4 |
fup_cva_90days |
3 (1.3%) |
0 (0%) |
3 (1.8%) |
0.6 |
sex |
|
|
|
0.9 |
Male |
123 (53%) |
33 (52%) |
90 (54%) |
|
Female |
108 (47%) |
30 (48%) |
78 (46%) |
|
age |
73 (66, 80) |
74 (67, 81) |
73 (65, 80) |
0.7 |
race |
|
|
|
0.7 |
White or Caucasian |
202 (87%) |
58 (92%) |
144 (86%) |
|
Other |
16 (6.9%) |
3 (4.8%) |
13 (7.7%) |
|
Black or African American |
12 (5.2%) |
2 (3.2%) |
10 (6.0%) |
|
Asian |
1 (0.4%) |
0 (0%) |
1 (0.6%) |
|
anti_coag_at_disch |
130 (56%) |
45 (71%) |
85 (51%) |
0.004 |
anti_coags_at_re_admit_afib |
40 (63%) |
40 (63%) |
0 (NA%) |
|
CHADS_TOTAL |
|
|
|
0.013 |
5 |
64 (28%) |
25 (40%) |
39 (23%) |
|
4 |
63 (27%) |
9 (14%) |
54 (32%) |
|
3 |
54 (23%) |
15 (24%) |
39 (23%) |
|
2 |
23 (10.0%) |
4 (6.3%) |
19 (11%) |
|
6 |
22 (9.5%) |
10 (16%) |
12 (7.1%) |
|
7 |
3 (1.3%) |
0 (0%) |
3 (1.8%) |
|
1 |
1 (0.4%) |
0 (0%) |
1 (0.6%) |
|
8 |
1 (0.4%) |
0 (0%) |
1 (0.6%) |
|
MODEL 1 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post cardiac surgery
## fup_afib_90days n
## 1 0 501
## 2 1 105
Characteristic |
OR |
95% CI |
p-value |
age |
0.99 |
0.97, 1.01 |
0.3 |
sex |
|
|
|
Female |
— |
— |
|
Male |
1.44 |
0.88, 2.40 |
0.2 |
htn |
1.31 |
0.76, 2.28 |
0.3 |
dm |
1.70 |
0.92, 3.06 |
0.082 |
cva |
0.96 |
0.34, 2.44 |
>0.9 |
chf |
2.93 |
1.55, 5.44 |
<0.001 |
mi |
1.65 |
0.75, 3.41 |
0.2 |
osa |
0.67 |
0.30, 1.41 |
0.3 |
copd |
5.96 |
2.92, 12.3 |
<0.001 |
hld |
1.23 |
0.75, 2.02 |
0.4 |
ckd |
2.08 |
0.58, 6.59 |
0.2 |
MODEL 2 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post NON-cardiac surgery
## fup_afib_90days n
## 1 0 168
## 2 1 63
Characteristic |
OR |
95% CI |
p-value |
age |
1.01 |
0.99, 1.04 |
0.3 |
sex |
|
|
|
Female |
— |
— |
|
Male |
0.99 |
0.51, 1.90 |
>0.9 |
htn |
1.85 |
0.91, 3.78 |
0.090 |
dm |
1.87 |
0.77, 4.47 |
0.2 |
cva |
0.41 |
0.08, 1.58 |
0.2 |
chf |
2.49 |
0.87, 7.10 |
0.085 |
mi |
2.43 |
0.81, 7.28 |
0.11 |
osa |
2.43 |
0.78, 7.78 |
0.13 |
copd |
1.60 |
0.60, 4.15 |
0.3 |
hld |
0.96 |
0.47, 1.92 |
0.9 |
ckd |
1.19 |
0.19, 6.42 |
0.8 |
MODEL 3 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post cardiac surgery TAKING ONLY P<0.1 IN UNIVARIATE
## fup_afib_90days n
## 1 0 501
## 2 1 105
Characteristic |
OR |
95% CI |
p-value |
Age |
0.99 |
0.97, 1.01 |
0.4 |
Gender |
|
|
|
Female |
— |
— |
|
Male |
1.41 |
0.87, 2.35 |
0.2 |
Diabetes mellitus |
1.66 |
0.90, 2.97 |
0.10 |
Myocardial infarction |
1.64 |
0.75, 3.36 |
0.2 |
Chronic obstructive pulmonary disease |
5.58 |
2.77, 11.3 |
<0.001 |
Heart failure |
2.88 |
1.53, 5.34 |
<0.001 |
Hyperlipidemia |
1.19 |
0.73, 1.97 |
0.5 |
Hypertension |
1.27 |
0.74, 2.21 |
0.4 |
Chronic Kiendy Disease |
2.13 |
0.61, 6.67 |
0.2 |
MODEL 4 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post NON-cardiac surgery TAKING ONLY P<0.1 IN UNIVARIATE
## fup_afib_90days n
## 1 0 168
## 2 1 63
Characteristic |
OR |
95% CI |
p-value |
age |
1.01 |
0.98, 1.04 |
0.5 |
sex |
|
|
|
Female |
— |
— |
|
Male |
1.09 |
0.58, 2.06 |
0.8 |
dm |
2.05 |
0.87, 4.79 |
0.10 |
mi |
2.27 |
0.76, 6.64 |
0.13 |
copd |
1.57 |
0.61, 3.94 |
0.3 |
chf |
2.26 |
0.80, 6.30 |
0.12 |
htn |
1.86 |
0.93, 3.75 |
0.079 |
hld |
0.99 |
0.50, 1.95 |
>0.9 |
ckd |
1.38 |
0.24, 7.13 |
0.7 |
MODEL 5 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post cardiac surgery
WITH CHADS-VASC SCORE and ther vars without CKD and HLD
## fup_afib_90days n
## 1 0 501
## 2 1 105
Characteristic |
OR |
95% CI |
p-value |
CHADS_TOTAL |
1.10 |
0.91, 1.32 |
0.3 |
copd |
6.17 |
3.14, 12.3 |
<0.001 |
osa |
0.96 |
0.44, 1.92 |
>0.9 |
MODEL 6 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post cardiac surgery
WITH CHADS-VASC SCORE and ther vars with CKD and HLD
## fup_afib_90days n
## 1 0 501
## 2 1 105
Characteristic |
OR |
95% CI |
p-value |
CHADS_TOTAL |
1.05 |
0.87, 1.28 |
0.6 |
copd |
6.38 |
3.22, 12.8 |
<0.001 |
osa |
0.89 |
0.41, 1.80 |
0.8 |
ckd |
2.20 |
0.62, 6.89 |
0.2 |
hld |
1.42 |
0.90, 2.25 |
0.13 |
MODEL 7 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post NON-cardiac surgery
WITH CHADS-VASC SCORE and ther vars without CKD and HLD
## fup_afib_90days n
## 1 0 168
## 2 1 63
Characteristic |
OR |
95% CI |
p-value |
CHADS_TOTAL |
1.25 |
0.98, 1.61 |
0.074 |
copd |
1.58 |
0.65, 3.72 |
0.3 |
osa |
2.85 |
1.04, 7.82 |
0.040 |
MODEL 8 LOGISTIC REGRESSION Predictors of Afib recurrance in patients post NON-cardiac surgery
WITH CHADS-VASC SCORE and ther vars with CKD and HLD
## fup_afib_90days n
## 1 0 168
## 2 1 63
Characteristic |
OR |
95% CI |
p-value |
CHADS_TOTAL |
1.26 |
0.97, 1.63 |
0.084 |
copd |
1.50 |
0.59, 3.65 |
0.4 |
osa |
2.87 |
1.02, 8.17 |
0.044 |
ckd |
1.43 |
0.24, 7.39 |
0.7 |
hld |
0.97 |
0.49, 1.87 |
>0.9 |
MODEL 9
Characteristic |
OR |
95% CI |
p-value |
Gender |
|
|
|
Female |
— |
— |
|
Male |
0.97 |
0.52, 1.83 |
>0.9 |
Age |
1.01 |
0.99, 1.04 |
0.3 |
Diabetes mellitus |
1.95 |
0.82, 4.54 |
0.12 |
Heart failure |
2.39 |
0.86, 6.51 |
0.087 |
Obstructive sleep apnea |
2.78 |
0.92, 8.53 |
0.068 |
Hypertension |
1.82 |
0.95, 3.56 |
0.075 |
##
## Call: glm(formula = fup_afib_90days ~ Gender + Age + `Diabetes mellitus` +
## `Heart failure` + `Obstructive sleep apnea` + Hypertension,
## family = "binomial", data = non_cs_data)
##
## Coefficients:
## (Intercept) GenderMale
## -2.57255 -0.02770
## Age `Diabetes mellitus`
## 0.01382 0.66628
## `Heart failure` `Obstructive sleep apnea`
## 0.87065 1.02299
## Hypertension
## 0.59917
##
## Degrees of Freedom: 226 Total (i.e. Null); 220 Residual
## (4 observations deleted due to missingness)
## Null Deviance: 266.2
## Residual Deviance: 248.5 AIC: 262.5